Harmony Biosciences Holdings (HRMY) EBT Margin (2020 - 2026)
Harmony Biosciences Holdings (HRMY) reported EBT Margin of 18.43% for Q1 2026, down 1253.0% on a YoY basis from 1.6% in Q1 2025, and up 10.2% sequentially from 16.72% in Q4 2025.
Harmony Biosciences Holdings (HRMY) EBT Margin (2020 - 2026) Analysis & Trends
Harmony Biosciences Holdings (HRMY) has 7 years of EBT Margin data on file, last reported at 18.43% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin fell 1253.0% year-over-year to 18.43%; the trailing twelve-month figure through Mar 2026 stood at 21.97% (down 450.0% YoY), and the FY2025 full-year result was 24.76%, down 207.0% from the prior year.
- EBT Margin climbed to 18.43% in Q1 2026, from 16.72% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 34.37% in Q4 2022 to a low of 6.8% in Q3 2022.
- A 5-year average of 26.05% and a median of 27.9% in 2024 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin soared 2554 bps in 2023 and tumbled 2030 bps in 2024, its largest moves.
- Tracing HRMY's EBT Margin over 5 years: stood at 34.37% in 2022, then tumbled by 31 bps to 23.57% in 2023, then advanced by 18 bps to 27.9% in 2024, then sank by 40 bps to 16.72% in 2025, then increased by 10 bps to 18.43% in 2026.
- Business Quant data shows HRMY's EBT Margin at 18.43% in Q1 2026, 16.72% in Q4 2025, and 28.18% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Harmony Biosciences Holdings | 2.07 Bn | 1.55 Bn | 170.88 Mn | 18.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.43% |
| Dec 31, 2025 | 16.72% |
| Sep 30, 2025 | 28.18% |
| Jun 30, 2025 | 24.76% |
| Mar 31, 2025 | 30.95% |
| Dec 31, 2024 | 27.90% |
| Sep 30, 2024 | 33.42% |
| Jun 30, 2024 | 12.55% |
| Mar 31, 2024 | 33.49% |
| Dec 31, 2023 | 23.57% |
| Sep 30, 2023 | 32.34% |
| Jun 30, 2023 | 32.85% |
| Mar 31, 2023 | 31.71% |
| Dec 31, 2022 | 34.37% |
| Sep 30, 2022 | 6.80% |
| Jun 30, 2022 | 27.31% |
| Mar 31, 2022 | 27.41% |
| Dec 31, 2021 | 26.83% |
| Sep 30, 2021 | -13.03% |
| Jun 30, 2021 | 21.79% |